John K Bakewell bought stock once, on May 10, 2024

John K. Bakewell is a corporate director and experienced life sciences executive who serves on the Board of Directors of Treace Medical Concepts, Inc. (NASDAQ: TMCI), where he is a director and member of the Audit Committee as well as the Nominating and Corporate Governance Committee.( He has nearly three decades of senior executive experience in the medical device, specialty pharmaceutical, diagnostics, and healthcare provider sectors, with a long track record of building and executing growth strategies for both public and private companies.( Bakewell has recently reported equity-based insider transactions at Treace Medical Concepts in connection with routine board compensation awards, including the receipt of restricted stock units as part of his director compensation.(

Earlier in his career, Bakewell spent nine years as Executive Vice President and Chief Financial Officer of Wright Medical Group, Inc., where he helped lead the company from a private equity–backed reorganization through its initial public offering and the development of an industry-leading lower extremities franchise.( He has held the Chief Financial Officer role at multiple companies, including several publicly traded firms such as Lantheus Holdings, Cyberonics, Zeos International, and others, and began his career as a CPA with KPMG and Ernst & Young serving growth-oriented businesses across industries.( In addition to his role at Treace, he has served on various boards and audit committees for medical technology and healthcare companies, reflecting deep expertise in financial leadership, corporate governance, and shareholder value creation.(

Written by Perplexity from public sources.